Gregory J. Flesher's Net Worth
-$49.7 Thousand
Who is Gregory J. Flesher?
Gregory J. Flesher does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Reneo Pharmaceuticals, Inc., Adynxx, Inc., and Novus Therapeutics, Inc..
SEC CIK
Gregory J. Flesher's CIK is 0001705287
Past Insider Trading and Trends
2019 was Gregory J. Flesher's most active year for acquiring shares with 3 total transactions. Gregory J. Flesher's most active month to acquire stocks was the month of February. 2019 was Gregory J. Flesher's most active year for disposing of shares, totalling 2 transactions. Gregory J. Flesher's most active month to dispose stocks was the month of April. 2017 saw Gregory J. Flesher paying a total of $589,000.41 for 308,959 shares, this is the most they've acquired in one year. In 2019 Gregory J. Flesher cashed out on 14,638 shares for a total of $28,566.46, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
| +1,041.67% | 100K |
—
|
—
| 109.6K |
Dec 10
| |||
Form 4
|
∞
| 8K |
$8.00 | $64,000.00 | 8K |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adynxx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Novus Therapeutics, Inc. (ELDN) Snapshot price: $2.664
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 4
| -8.53% | -14.64K |
$1.95 | -$28,566.46 | 156.92K |
May 20 - May 21
| |||
Form 4
| +17.06% | 25K |
—
|
—
| 171.56K |
Mar 14
| |||
Form 4
| +26.50% | 30.7K |
—
|
—
| 146.56K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +103.62% | 58.96K |
$9.99 | $589,000.41 | 115.86K |
May 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||